(164) found that the low levels of expression of CXCL9 and PD-L1 were unfavorable prognostic factors in non-muscle-invasive bladder cancer, which suggested that the anti-tumor effect of CXCL9-mediated immune function may depend in part on the progression of tumorigenesis. The gene discussed is CXCL9; the disease is neoplasm.